Drug development and capacity building partnership for cancer research
Official title: 1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
Funded at Beckman Research Institute/city of Hope · NIH-11415815 · Data updated 2026-11-12
A joint effort between UC Riverside and City of Hope to build resources, training, and collaboration so researchers can move promising cancer ideas toward new drugs and clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $1,380,456 |
| NIH project number | 5U54CA285116-04 |
| Project ID | NIH-11415815 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with breast cancer or other cancers linked to the program's focus may be eligible for future trials and access to novel therapies.
✕Less likely to help
Not all ideas will advance to clinical trials, and individual patient benefits depend on future discoveries and trial availability.
What this research studies
This grant supports a partnership to strengthen drug development capacity, infrastructure, and training across UCR and City of Hope. It aims to help UCR scientists advance ideas into therapies and clinical trials, with a focus on cancer biology and translational research. The program builds on prior successes and seeks to mentor the next generation of cancer researchers, including clinicians and trialists. It emphasizes collaborations, shared resources, and mentorship to accelerate the drug development pipeline.
Why it matters
Potential benefit: If successful, patients could benefit from faster development of new cancer therapies and more opportunities to participate in clinical trials.
How similar studies have gone: The partners have already generated joint grants and fellowships, showing a track record of successful collaboration in cancer drug development.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Seewaldt, Victoria L. — Beckman Research Institute/city of Hope
- Study coordinator: Seewaldt, Victoria L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.